Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

EMBO Journal

Volumn 20, Issue 17, 2001, Pages 4762-4773

  Mäkinen, Taija ^a   Veikkola, Tanja ^a   Mustjoki, Satu ^b   Karpanen, Terhi ^a   Catimel, Bruno ^c   Nice, Edouard C ^c   Wise, Lyn ^d   Mercer, Andrew ^d   Kowalski, Heinrich ^e   Kerjaschki, Dontscho ^e   Stacker, Steven A ^c   Achen, Marc G ^c   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelium; Flt4; Lymphatic; LYVE 1; Podoplanin

Indexed keywords

ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; RECEPTOR SUBTYPE; VASCULOTROPIN RECEPTOR; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL MIGRATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYMPH VESSEL ENDOTHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; BIOSENSING TECHNIQUES; CAPILLARIES; CELL DIVISION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; KINETICS; LYMPHATIC SYSTEM; MAP KINASE SIGNALING SYSTEM; MICROCIRCULATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; SKIN; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

ANIMALIA;

EID: 0242624291     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.17.4762     Document Type: Article

References (61)

1. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flkl) and VEGF receptor 3 (Flt4)
2. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3
3. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
4. The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man
5. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
6. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
7. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase
8. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium
9. Vascular endothelial growth factor C induces angiogenesis in vivo
10. Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategies
11. Mammalian MAP kinase signalling cascades
12. Cellular survival: A play in three Akts
13. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases
14. CREB is a regulatory target for the protein kinase Akt/PKB
15. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
16. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors
17. Molecular and biological properties of vascular endothelial growth factor
18. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
19. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
20. Purification and characterization of a growth factor-like which increases capillary permeability from Vipera lebetina venom
21. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
22. VEGF is required for growth and survival in neonatal mice
23. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration
24. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)-a reassessment using novel receptor-specific vascular endothelial growth factor mutants
25. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
26. Enhancement of migration by protein kinase Cα and inhibition of proliferation and cell cycle progression by protein kinase Cδ in capillary endothelial cells
27. Endothelial proliferation, migration and differentiation are blunted by conditionally expressed protein kinase C pseudosubstrate peptides
28. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis
29. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
30. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
31. Proteolytic processing regulates receptor specificity and activity of VEGF-C
32. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation and vascular permeability activities
33. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
34. Expression of the fins-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development
35. Conversion of TNFα from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase
36. Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper)
37. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors
38. C-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
39. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
40. Vascular endothelial growth factor activates CREB by signaling through the KDR receptor tyrosine kinase
41. pEF-BOS, a powerful mammalian expression vector
42. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
43. Instrumental biosensors: New perspectives for the analysis of biomolecular interactions
44. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors
45. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
46. Endothelial growth factor receptors in human fetal heart
47. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues
48. Signaling via vascular endothelial growth factor receptors
49. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase
50. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
51. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
52. Failure of blood island formation and vasculogenesis in Flk-l-deficient mice
53. Structure and function of vascular endothelial growth factor receptor-1 and -2
54. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability
55. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
56. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling
57. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
58. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1
59. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
60. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis
61. Phosphorylation and regulation of Raf by Akt (protein kinase B)